ERBB2 and breast carcinoma: In addition, TMB represents tumor heterogeneity and immunogenicity, which varies across breast cancer subtypes, with TNBC and HER2+ tumors harboring relatively high mutation rates, while TMB-H is uncommon in breast cancer.